Skip to content

Clinical and Jaw Tracking Assessment Following Intra-articular Injection of PRP and HA in TMJ Disc Displacement With Reduction

Biomechanical Assessment of Platelet Rich Plasma and Hyaluronic Acid Intra-articular Injection in Temporomandibular Joint Internal Derangement Using a Jaw Tracking Device

Status
Completed
Phases
Unknown
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT07643402
Enrollment
20
Registered
2026-06-11
Start date
2025-07-01
Completion date
2026-05-05
Last updated
2026-09-08

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Temporomandibular Joint Disc Displacement, With Reduction

Keywords

tmj, disc displacement with reduction, jaw tracking, hyaluronic acid, prp, Temporomandibular Disorders, Zebris, Joint clicking, Maximum Mouth Opening, Intra-articular Injection

Brief summary

Assessment of intra-articular injection of hyaluronic acid and prp within TMJ using the Zebris jaw tracking device as an objective method

Interventions

A combination of Autologous Platelet-Rich Plasma prepared from the patient's blood and hyaluronic acid injected intra-articularly

Sponsors

Mansoura University
Lead SponsorOTHER

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
TREATMENT
Masking
NONE

Masking description

The clinical outcomes assessor and MRI assessor were blinded to the intervention details during outcome assessment.

Eligibility

Sex/Gender
ALL
Age
18 Years to 45 Years
Healthy volunteers
No

Inclusion criteria

1. The patients' ages range from 18 to 45. 2. Patients experienced clicking sounds, painful joints, and restricted mouth opening. 3. Individuals whose MRI confirms a unilateral internal abnormality with reduction. 4. A patient who did not respond to conservative treatment. 5 • The patient's capacity and willingness to finish the course of therapy and subsequent appointments.

Exclusion criteria

1. A patient suffering from a connective tissue or inflammatory condition. 2. A patient who has had TMJ surgery in the past. 3. A history of injecting any kind of material into the target TMJ. 4. Drug allergy history. 5. A patient who has previously had fibrous or bony adhesion. 6. A patient experiencing psychological issues.

Design outcomes

Primary

MeasureTime frameDescription
Mandibular movements assessed using the zebris JMABaseline, 1monthchanges in mandibular movements assessed using the Zebris Jaw Motion Analyzer (JMA) system following treatment

Secondary

MeasureTime frameDescription
Pain Assessment using the Visual Analogue Scalebaseline, 1 week, 1 month, 3months, 6 monthsChanges in pain intensity assessed using the Visual Analog Scale (VAS), a 0-10 scale where 0 indicates no pain and 10 indicates the worst imaginable pain; higher scores indicate greater pain severity. Measurements will be obtained at baseline, 1 week, 1 month, 3 months, and 6 months following intra-articular injection of hyaluronic acid and platelet-rich plasma (PRP) in patients with temporomandibular joint disc displacement with reduction.
clicking soundBaseline, 6 monthschanges in clicking sound following treatment
MRI assessment of the temporomandibular jointAt baseline and 6 months after treatmentMRI assessment of the temporomandibular joint, including disc position and retrodiscal tissue changes,

Countries

Egypt

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Sep 9, 2026